Par Pharmaceutical Inc. recalls Glycopyrrolate Tablets, USP 1 mg, 100-count bottle, Rx only, Dist. by: Par Pharmaceutical, Chestnut Ridge, NY, 10977,
Par Pharmaceutical recalls 100-count Glycopyrrolate Tablets (1mg) due to unknown impurities. Rx-only medication with NDC 49884-0065-01 and lot #32809101. No specific action steps listed in recall notice.
Recall notice
Failed Impurities/Degradation Specification: Presence of unknown impurity observed.
Contact the company & request your remedy
What happened, in plain English
Par Pharmaceutical is recalling 100-count Glycopyrrolate Tablets (1mg) that were made in India. The recall is due to the presence of an unknown impurity that could affect safety. Read more at govinfonow.com/recall/37207-par-pharmaceutical-glycopyrrolate-tablets-1mg-recall-unknown-impurity-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/37207-par-pharmaceutical-glycopyrrolate-tablets-1mg-recall-unknown-impurity-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-1071-2020
Cite this page
“Par Pharmaceutical Glycopyrrolate Tablets 1mg Recall: Unknown Impurity Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37207-par-pharmaceutical-glycopyrrolate-tablets-1mg-recall-unknown-impurity-risk. Based on FDA recall #D-1071-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1071-2020%22&limit=1).
Why it’s dangerous
The tablets contain an unknown impurity that may pose a safety risk. This impurity could potentially affect the medication's safety profile, though the exact risk is not specified in the recall notice.
Who’s affected
Prescription patients who have the 100-count Glycopyrrolate Tablets (1mg) with NDC 49884-0065-01 and lot #32809101 are affected. Patients using this medication for medical purposes are at risk.
How to tell if you have this one
Check for the 100-count bottle labeled 'Glycopyrrolate Tablets, USP 1 mg' with NDC number 49884-0065-01 and lot number 32809101. The product was manufactured in India and distributed by Par Pharmaceutical.
- Brand
Par Pharmaceutical- Category
Drug
What to do — step by step
Check Product Details
Verify the NDC number 49884-0065-01 and lot number 32809101 on the product label.
Questions people ask
Is this product safe to use?
The recall notice states there is an unknown impurity, but does not specify if the product is safe to use. No specific action steps are listed.
What should I do if I have this product?
The recall notice does not provide specific action steps for affected products. Check the product details and contact your healthcare provider for guidance.
Is there a risk of serious injury?
The recall notice mentions an unknown impurity but does not describe a specific risk of serious injury or harm.
Contact Par Pharmaceutical
We’ve drafted a message you can send Par Pharmaceutical to request your refund or repair — edit it as you like.
Subject: Recall D-1071-2020 — Par Pharmaceutical Par Pharmaceutical Hello, I own a Par Pharmaceutical that is covered by recall D-1071-2020 from Par Pharmaceutical. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1071-2020 (March 30, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1071-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.